|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Keane MG and Johnson GJ: Early diagnosis
improves survival in colorectal cancer. Practitioner. 256:15–18, 2.
2012.PubMed/NCBI
|
|
4
|
Sturchler E, Cox JA, Durussel I, Weibel M
and Heizmann CW: S100A16, a novel calcium-binding protein of the
EF-hand superfamily. J Biol Chem. 281:38905–38917. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Donato R: S100: A multigenic family of
calcium-modulated proteins of the EF-hand type with intracellular
and extracellular functional roles. Int J Biochem Cell Biol.
33:637–668. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sedaghat F and Notopoulos A: S100 protein
family and its application in clinical practice. Hippokratia.
12:198–204. 2008.PubMed/NCBI
|
|
7
|
Heizmann CW: The multifunctional S100
protein family. Methods Mol Biol. 172:69–80. 2002.PubMed/NCBI
|
|
8
|
Domínguez B, Pardo BG, Noia M, Millán A,
Gómez-Tato A, Martínez P, Leiro J and Lamas J: Microarray analysis
of the inflammatory and immune responses in head kidney turbot
leucocytes treated with resveratrol. Int Immunopharmacol.
15:588–596. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li D, Zhang R, Zhu W, Xue Y, Zhang Y,
Huang Q, Liu M and Liu Y: S100A16 inhibits osteogenesis but
stimulates adipogenesis. Mol Biol Rep. 40:3465–3473. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Babini E, Bertini I, Borsi V, Calderone V,
Hu X, Luchinat C and Parigi G: Structural characterization of human
S100A16, a low-affinity calcium binder. J Biol Inorg Chem.
16:243–256. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang C, Zhu X, Li A, Yang S, Qiao R and
Zhang J: S100A16 regulated by Snail promotes the chemoresistance of
nonmuscle invasive bladder cancer through the AKT/Bcl-2 pathway.
Cancer Manag Res. 11:2449–2456. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen, Luo L and Liang C: Aberrant S100A16
expression might be an independent prognostic indicator of
unfavorable survival in non-small cell lung adenocarcinoma. PLoS
One. 13:e1974022018.
|
|
13
|
Zhou W, Pan H, Xia T, Xue J, Cheng L, Fan
P, Zhang Y, Zhu W, Xue Y, Liu X, et al: Up-regulation of S100A16
expression promotes epithelial-mesenchymal transition via Notch1
pathway in breast cancer. J Biomed Sci. 21:972014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sapkota D, Bruland O, Parajuli H, Osman
TA, Teh MT, Johannessen AC and Costea DE: S100A16 promotes
differentiation and contributes to a less aggressive tumor
phenotype in oral squamous cell carcinoma. BMC Cancer. 15:6312015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun X, Wang T, Zhang C, Ning K, Guan ZR,
Chen SX, Hong TT and Hua D: S100A16 is a prognostic marker for
colorectal cancer. J Surg Oncol. 117:275–283. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Skrzypczak M, Goryca K, Rubel T, Paziewska
A, Mikula M, Jarosz D, Pachlewski J, Oledzki J and Ostrowski J:
Modeling oncogenic signaling in colon tumors by multidirectional
analyses of microarray data directed for maximization of analytical
reliability. PLoS One. 5:52010. View Article : Google Scholar
|
|
17
|
Shi J, Sun S, Liao Y, Tang J, Xu X, Qin B,
Qin C, Peng L, Luo M, Bai L, et al: Advanced oxidation protein
products induce G1 phase arrest in intestinal epithelial cells via
a RAGE/CD36-JNK-p27kip1 mediated pathway. Redox Biol.
25:1011962019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang J, Liao Y, He S, Shi J, Peng L, Xu X,
Xie F, Diao N, Huang J, Xie Q, et al: Autocrine parathyroid
hormone-like hormone promotes intrahepatic cholangiocarcinoma cell
proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling. J
Transl Med. 15:2382017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu W, Xue Y, Liang C, Zhang R, Zhang Z,
Li H, Su D, Liang X, Zhang Y, Huang Q, et al: S100A16 promotes cell
proliferation and metastasis via AKT and ERK cell signaling
pathways in human prostate cancer. Tumour Biol. 37:12241–12250.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang MH, Zhao L, Wang L, Ou-Yang W, Hu SS,
Li WL, Ai ML, Wang YQ, Han Y, Li TT, et al: Nuclear lncRNA HOXD-AS1
suppresses colorectal carcinoma growth and metastasis via
inhibiting HOXD3-induced integrin β3 transcriptional activating and
MAPK/AKT signalling. Mol Cancer. 18:312019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schroyer AL, Stimes NW, Abi Saab WF and
Chadee DN: MLK3 phosphorylation by ERK1/2 is required for oxidative
stress-induced invasion of colorectal cancer cells. Oncogene.
37:1031–1040. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marenholz I and Heizmann CW: S100A16, a
ubiquitously expressed EF-hand protein which is up-regulated in
tumors. Biochem Biophys Res Commun. 313:237–244. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Duan L, Wu R, Zou Z, Wang H, Ye L, Li H,
Yuan S, Li X, Zha H, Sun H, et al: S100A6 stimulates proliferation
and migration of colorectal carcinoma cells through activation of
the MAPK pathways. Int J Oncol. 44:781–790. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Niu Y, Shao Z, Wang H, Yang J, Zhang F,
Luo Y, Xu L, Ding Y and Zhao L: LASP1-S100A11 axis promotes
colorectal cancer aggressiveness by modulating TGFβ/Smad signaling.
Sci Rep. 6:261122016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Masuda T, Ishikawa T, Mogushi K, Okazaki
S, Ishiguro M, Iida S, Mizushima H, Tanaka H, Uetake H and Sugihara
K: Overexpression of the S100A2 protein as a prognostic marker for
patients with stage II and III colorectal cancer. Int J Oncol.
48:975–982. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu B, Sun WY, Zhi CY, Lu TC, Gao HM, Zhou
JH, Yan WQ and Gao HC: Role of S100A3 in human colorectal cancer
and the anticancer effect of cantharidinate. Exp Ther Med.
6:1499–1503. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dahlmann M, Okhrimenko A, Marcinkowski P,
Osterland M, Herrmann P, Smith J, Heizmann CW, Schlag PM and Stein
U: RAGE mediates S100A4-induced cell motility via MAPK/ERK and
hypoxia signaling and is a prognostic biomarker for human
colorectal cancer metastasis. Oncotarget. 5:3220–3233. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zha H, Sun H, Li X, Duan L, Li A, Gu Y,
Zeng Z, Zhao J, Xie J, Yuan S, et al: S100A8 facilitates the
migration of colorectal cancer cells through regulating macrophages
in the inflammatory microenvironment. Oncol Rep. 36:279–290. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang HY, Zhang JY, Cui JT, Tan XH, Li WM,
Gu J and Lu YY: Expression status of S100A14 and S100A4 correlates
with metastatic potential and clinical outcome in colorectal cancer
after surgery. Oncol Rep. 23:45–52. 2010.PubMed/NCBI
|
|
31
|
Sapkota D, Costea DE, Ibrahim SO,
Johannessen AC and Bruland O: S100A14 interacts with S100A16 and
regulates its expression in human cancer cells. PLoS One.
8:e760582013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kobayashi M, Nagashio R, Saito K,
Aguilar-Bonavides C, Ryuge S, Katono K, Igawa S, Tsuchiya B, Jiang
SX, Ichinoe M, et al: Prognostic significance of S100A16
subcellular localization in lung adenocarcinoma. Hum Pathol.
74:148–155. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zeindl-Eberhart E, Brandl L, Liebmann S,
Ormanns S, Scheel SK, Brabletz T, Kirchner T and Jung A:
Epithelial-mesenchymal transition induces
endoplasmic-reticulum-stress response in human colorectal tumor
cells. PLoS One. 9:e873862014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tanaka M, Ichikawa-Tomikawa N, Shishito N,
Nishiura K, Miura T, Hozumi A, Chiba H, Yoshida S, Ohtake T and
Sugino T: Co-expression of S100A14 and S100A16 correlates with a
poor prognosis in human breast cancer and promotes cancer cell
invasion. BMC Cancer. 15:532015. View Article : Google Scholar : PubMed/NCBI
|
